Abstract
In a previous study, we found that synovial immunopathology differs between Behçet disease (BD) and psoriatic arthritis (PsA). The objective of this study is to describe the macroscopic features of early untreated knee synovitis in BD and PsA. Fourteen consecutive patients with active early knee synovitis (seven BD and seven PsA) undergoing rheumatologic arthroscopy were assessed. The following macroscopic synovial features were evaluated and scored by analyzing the video recordings of each procedure: capillary hyperaemia, morphology of synovitis, vascular pattern, fibrinoid membranes, and topographic distribution of these features. Video-recording of 35 early untreated arthritis patients with different diagnoses were also studied looking for BD-like macroscopic features. Six out of seven BD patients had extensive fibrinoid membranes and large areas of erythematous synovitis without villi or a distinctive vascular pattern, while PsA patients had diffuse erythematous villous synovitis with a tortuous vascular morphology. None of the 35 patients with early untreated arthritis exhibited all the characteristic features of BD synovitis. This exploratory study shows some distinctive features between BD and PsA knee synovitis that confirm macroscopic differences in patients with previously reported immunopathological differences.
Similar content being viewed by others
References
Fessler BJ (2005) Behçet’s syndrome. In: Moreland LW, Koopman WJ (eds) Arthritis and allied conditions. Lippincott Wiliams & Wilkins, Philadelphia, pp 1835–1844
Yurdakul S, Yazici H, Tüzün Y, Pazarli H, Yalçin B, Altaç M et al (1983) The arthritis of Behçet’s disease: a prospective study. Ann Rheum Dis 42:505–515
Kim HA, Choi KW, Song YW (1997) Arthropathy in Behcet’s disease. Scand J Rheumatol 26:125–129
Direskeneli H (2006) Autoimmunity vs autoinflammation in Behçet’s disease: do we oversimplify a complex disorder? Rheumatology (Oxford) 45:1461–1465
Yazici H, Fresko I, Yurdakul S (2007) Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 3:148–155
Ritchlin C (2007) Psoriatic disease—from skin to bone. Nat Clin Pract Rheumatol 3:698–706
Cañete JD, Celis R, Noordenbos T, Moll C, Gómez-Puerta JA, Pizcueta P et al (2009) Distinct synovial immunopathology in Behcet disease and psoriatic arthritis. Arthritis Res Ther 11:R17
Reece RJ, Cañete JD, Parsons WJ, Emery P, Veale DJ (1999) Distinct vascular patterns of early synovitis in psoriatic, reactive and rheumatoid arthritis. Arthritis Rheum 42:1481–1484
Fiocco U, Cozzi L, Chieco-Bianchi F, Rigou C, Vezzu M, Favero E et al (2001) Vascular changes in psoriatic knee joint synovitis. J Rheumatol 28:2840–2846
Cañete JD, Rodríguez JR, Salvador G, Gómez-Centeno A, Muñoz-Gómez J, Sanmartí R (2003) Diagnostic usefullness of synovial vascular morphology in chronic arthritis. A systematic survey of 100 cases. Semin Arthritis Rheum 32:378–387
Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF et al (2003) Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 30:260–268
O’Rourke KS, Ike RW (1994) Diagnostic arthroscopy in the arthritis patient. Rheum Dis Clin North Am 20:321–342
Lindblad S, Hedfors E (1985) Intraarticular variation in synovitis. Local macroscopic and microscopic signs of inflammatory activity are significantly correlated. Arthritis Rheum 28:977–986
International Study Group for Behcet’s disease (1990) Criteria for diagnosis of Behcet’s disease. Lancet 335:1078–1080
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2671
Humby F, Gullick N, Kelly S, Pitzalis C, Oakley SP (2008) A synovial pathergy reaction leading to a pseudo-septic arthritis and a diagnosis of Behçet disease. Rheumatology (Oxford) 47:1255–1256
Baeten D, Demetter P, Cuvelier C, Van Den Bosch F, Kruithof E, Van Damme N et al (2000) Comparative study of the synovial histology in rheumatoid arthritis, spondyloarthropathy, and osteoarthritis: influence of disease duration and activity. Ann Rheum Dis 59:945–953
Cañete JD, Pablos JL, Sanmartí R, Mallofré C, Marsal S, Maymó J et al (2004) Antiangiogenic effects of anti-tumor necrosis factor α therapy with infliximab in psoriatic arthritis. Arthritis Rheum 50:1636–1641
Goedkoop AY, Kraan MC, Picavet DI, de Rie MA, Teunissen MB, Bos JD et al (2004) Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study. Arthritis Res Ther 6:R326–R334
Salvador G, Sanmartí R, Gil-Torregrosa B, García-Peiró A, Rodríguez-Cros JR, Cañete JD (2006) Synovial vascular patterns and angiogenic factors expression in synovial tissue and serum of patients with rheumatoid arthritis. Rheumatology (Oxford) 45:966–971
Acknowledgment
This work was supported by grants from the Spanish Health Ministry, FIS (PI 04/1027 and PI 04/1023).
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Concepción Moll and Mónica Bogas contributed equally to this article.
Rights and permissions
About this article
Cite this article
Moll, C., Bogas, M., Gómez-Puerta, J.A. et al. Macroscopic features of knee synovitis in early untreated Behçet disease and psoriatic arthritis. Clin Rheumatol 28, 1053–1057 (2009). https://doi.org/10.1007/s10067-009-1205-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-009-1205-0